Cochlear | COH - Vermögenswerte

Aktienkurs
172.10
Täglich Wechseln
-1.34 -0.77%
Monatlich
-6.17%
Jährlich
-31.32%
Q2 Prognose
168.61




Vermögenswerte Veränderung Datum
Ansell USD 3.33B 3.2M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Fisher Paykel Healthcare NZD 2.63B 80.5M 2025-12
Healius AUD 3.07B 84.2M 2024-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Mayne Pharma AUD 1.14B 9.47M 2024-06
Mesoblast USD 782.31M 2.38M 2025-12
Monash IVF AUD 510.21M 17.6M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
Regis Healthcare AUD 2.6B 494.01M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Somnomed AUD 62.49M 2.16M 2023-06
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12